Investigation of the effects of urotensin II receptors in LPS-induced inflammatory response in HUVEC cell line through calcineurin/NFATc/IL-2 pathway.

[1]  M. Singer,et al.  Sepsis therapies: learning from 30 years of failure of translational research to propose new leads , 2020, EMBO molecular medicine.

[2]  D. Bruzzese,et al.  Urotensin II receptor expression in prostate cancer patients: A new possible marker , 2019, The Prostate.

[3]  E. Akpinar,et al.  Urotensin receptors as a new target for CLP induced septic lung injury in mice , 2018, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  H. Tsujimoto,et al.  Mechanisms of sepsis‐induced immunosuppression and immunological modification therapies for sepsis , 2018, Annals of gastroenterological surgery.

[5]  J. Christman,et al.  Inhibition of nuclear factor of activated T cells (NFAT) c3 activation attenuates acute lung injury and pulmonary edema in murine models of sepsis , 2018, Oncotarget.

[6]  I. Cinar,et al.  The role of urotensin‐II and its receptors in sepsis‐induced lung injury under diabetic conditions , 2018, European journal of pharmacology.

[7]  Y. Yu,et al.  The Inflammation Induced by Lipopolysaccharide can be Mitigated by Short‐chain Fatty Acid, Butyrate, through Upregulation of IL‐10 in Septic Shock , 2017, Scandinavian journal of immunology.

[8]  Aizhong Wang,et al.  Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  Y. Bayir,et al.  Blocking of urotensin receptors as new target for treatment of carrageenan induced inflammation in rats , 2016, Peptides.

[10]  A. Hoffmann,et al.  Signaling via the NFκB system , 2016, Wiley interdisciplinary reviews. Systems biology and medicine.

[11]  J. Christman,et al.  The Transcription Factor Nuclear Factor of Activated T Cells c3 Modulates the Function of Macrophages in Sepsis , 2014, Journal of Innate Immunity.

[12]  Maria F. Gomez,et al.  Nuclear Factor of Activated T Cells Regulates Neutrophil Recruitment, Systemic Inflammation, and T-Cell Dysfunction in Abdominal Sepsis , 2014, Infection and Immunity.

[13]  T. van der Poll,et al.  Severe sepsis and septic shock. , 2013, The New England journal of medicine.

[14]  M. Létourneau,et al.  Update on the urotensinergic system: new trends in receptor localization, activation, and drug design , 2012, Front. Endocrin..

[15]  Esther G. L. Koh,et al.  Calcineurin/NFAT signalling inhibits myeloid haematopoiesis , 2012, EMBO molecular medicine.

[16]  S. Plevy,et al.  A Cell Permeable Peptide Inhibitor of NFAT Inhibits Macrophage Cytokine Expression and Ameliorates Experimental Colitis , 2012, PloS one.

[17]  Fabio Silvio Taccone,et al.  Microcirculatory alterations: potential mechanisms and implications for therapy , 2011, Annals of intensive care.

[18]  A. Oral,et al.  The Effects of Montelukast on Antioxidant Enzymes and Proinflammatory Cytokines on the Heart, Liver, Lungs, and Kidneys in a Rat Model of Cecal Ligation and Puncture–Induced Sepsis , 2011, TheScientificWorldJournal.

[19]  C. Ince,et al.  The response of the host microcirculation to bacterial sepsis: does the pathogen matter? , 2010, Journal of Molecular Medicine.

[20]  M. Foti,et al.  CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation , 2009, Nature.

[21]  S. P. Young,et al.  Nociceptin and urotensin-II concentrations in critically ill patients with sepsis. , 2008, British journal of anaesthesia.

[22]  Yu-guang Li,et al.  Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta , 2008, Journal of hypertension.

[23]  E. Mendis,et al.  Inhibition of inducible nitric oxide synthase and cyclooxygenase‐2 in lipopolysaccharide‐stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down‐regulation of mitogen‐activated protein kinase‐mediated nuclear factor‐κB signaling , 2008, Immunology.

[24]  S. Bhandari,et al.  Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans. , 2007, International journal of cardiology.

[25]  C. Zoccali.  Urotensin in ESRD: not so surprising. , 2006, Kidney international.

[26]  P. Ricciardi-Castagnoli,et al.  Natural killer (NK) cell functions can be strongly boosted by activated dendritic cells (DC). , 2006, European journal of immunology.

[27]  P. Ricciardi-Castagnoli,et al.  Induction of Peripheral T Cell Tolerance by Antigen-Presenting B Cells. II. Chronic Antigen Presentation Overrules Antigen-Presenting B Cell Activation1 , 2006, The Journal of Immunology.

[28]  Can Ince,et al.  The microcirculation is the motor of sepsis , 2005, Critical care.

[29]  P. Molenaar,et al.  Activation of calcineurin in human failing heart ventricle by endothelin‐1, angiotensin II and urotensin II , 2005, British journal of pharmacology.

[30]  F. Macian,et al.  NFAT proteins: key regulators of T-cell development and function , 2005, Nature Reviews Immunology.

[31]  M. Colombo,et al.  CD40/CD40L interaction regulates CD4+CD25+ T reg homeostasis through dendritic cell‐produced IL‐2 , 2005, European journal of immunology.

[32]  M. Haase,et al.  Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down‐regulation upon myeloid differentiation , 2004, Journal of leukocyte biology.

[33]  T. Malek,et al.  Tolerance, not immunity, crucially depends on IL-2 , 2004, Nature Reviews Immunology.

[34]  S. Douglas,et al.  Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. , 2004, Atherosclerosis.

[35]  P. Ricciardi-Castagnoli,et al.  A Contribution of Mouse Dendritic Cell–Derived IL-2 for NK Cell Activation , 2004, The Journal of experimental medicine.

[36]  P. Ricciardi-Castagnoli,et al.  Early IL-2 Production by Mouse Dendritic Cells Is the Result of Microbial-Induced Priming1 , 2003, The Journal of Immunology.

[37]  M. Vadas,et al.  The Human IL-3 Locus Is Regulated Cooperatively by Two NFAT-Dependent Enhancers That Have Distinct Tissue-Specific Activities1 , 2002, The Journal of Immunology.

[38]  H. Myung,et al.  Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-alpha promoters. , 2002, Molecules and cells.

[39]  Maria Persico,et al.  Inducible IL-2 production by dendritic cells revealed by global gene expression analysis , 2001, Nature Immunology.

[40]  J. Oppenheim,et al.  Cytokines: Past, Present, and Future , 2001, International journal of hematology.

[41]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[42]  H. Sarau,et al.  Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 , 1999, Nature.

[43]  G. Crabtree,et al.  Identification of a putative regulator of early T cell activation genes. , 1988, Science.

[44]  R. Nishioka,et al.  Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[45]  H. Sugerman,et al.  Multisystem organ failure secondary to increased intraabdominal pressure , 2007, Infection.

[46]  N. Matsuda,et al.  Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. , 2006, Journal of Pharmacological Sciences.

[47]  K. Ley,et al.  Leucocyte-endothelial interactions in health and disease. , 2006, Handbook of experimental pharmacology.

[48]  D. Annane,et al.  Compartmentalization of the inflammatory response in sepsis and SIRS. , 2006, Journal of endotoxin research.

[49]  M. Greenblatt,et al.  Br Ief Definitive Repor T Calcineurin Regulates Innate Antifungal Immunity in Neutrophils , 2022 .